comparemela.com

(Reuters) -U.S. intelligence officials in late February told senators working on a biotech security bill that Chinese pharmaceutical firm WuXi AppTec had transferred U.S. intellectual property to Beijing without consent, according to two sources. The U.S. government is concerned that certain Chinese biotech companies are contributing technology or research and development for use by China's military, and the proposed legislation would restrict U.S. government funds going to those Chinese companies. The classified briefing to about a dozen senators was led by the FBI, the State Department and the Office of the Director of National Intelligence.

Related Keywords

China ,Washington ,United States ,Beijing ,Shanghai ,New York ,Hong Kong ,Chinese ,American ,John Crowley ,Daniel Wallis ,Caroline Humer ,Matthew Lewis ,Michael Martina ,Lisa Shumaker ,Mike Gallagher ,Rachel King ,Gary Peters ,Karen Freifeld ,National Intelligence ,Government Affairs ,Biotechnology Innovation Organization ,Us Senate Committee On Homeland Security ,Reuters ,Michael Erman ,Wuxi Apptec ,State Department ,Prohibiting Foreign Access ,American Genetic Information Act ,Democratic Senator Gary Peters ,Homeland Security ,Representative Mike Gallagher ,Chinese Companies ,National Security ,Intellectual Property ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.